PRN Meeting: December 13, 2023 Jointly provided by the Medical Society of the State of New York, at a Zoom webinar, 7:00 p.m. to 9:00 p.m (EST).

Target Audience:

Physicians, Nurse Practitioners, and Physician Assistants caring for people at risk for, or infected with HIV and/or viral hepatitis.

Course Director: James F. Braun, DO, President & Program Planner, Physicians' Research Network

Moderator: Joseph P. McGowan, MD, FACP, FIDSA, Professor, Inst. of Health System Science, Feinstein Inst. for Medical Research, Zucker School of Medicine, Hofstra/Northwell

Guest Speakers and Presentations:

HIV Post-Treatment Control: Insights On Remission from a Unique European Cohort

Asier Saez-Cirion, PhD

Head of Viral Reservoirs and Immune Control Unit
Institut Pasteur, Paris, France

At the completion of this educational activity learners will:
1. Be aware of markers that may help predict who among people on ART may have better chances to control viremia if ART is discontinued for any reason.
2. Understand the viral and host factors that have been associated with post-treatment control, as well as the immune mechanisms mobilized during acute infection vs treatment interruption.
3. Know the difference between HIV remission and HIV cure.
4. Understand how post-treatment controllers are different (or are not) from other cases of durable remission or potential HIV cure.

HIV Elite Controllers and What We’ve Learned from Them

Rajesh T. Gandhi, MD

Director, HIV Clinical Services and Education
Massachusetts General Hospital
Co-Director, Harvard Center for AIDS Research
Professor of Medicine, Harvard Medical School
Boston, Massachusetts

At the completion of this educational activity learners will:
1. Be aware of data on antiretroviral therapy in people with HIV (PWH) who are elite controllers.
2. Understand how HIV elite control may inform new cure strategies.
3. Know recent information on HIV reservoir decay in PWH who are receiving antiretroviral therapy.

Accreditation Statement:

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and the Physicians’ Research Network (PRN). MSSNY is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing Medical Education for physicians.

The Medical Society of the State of New York designates this live activity for a maximum 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Recognition Statement:

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Disclosure Statements:

Policies and standards of the Medical Society of the State of New York and the Accreditation Council for Continuing Medical Education require that speakers and planners for continuing medical education activities disclose any relevant financial relationships they may have with commercial interests whose products, devices, or services may be discussed in the content of a CME activity.
- Dr. James F. Braun (Course Director/Planner) has no relevant financial relationships to disclose.
- Dr. Joseph P. McGowan (Moderator) has no relevant financial relationships to disclose.
- Dr. Asier Sáez-Cirión (Presenter) has had the following personal financial relationships in the past 24 months with manufacturers of the products or services that may be presented in this CME activity: Research grants from Merck, and ViiV; Honorariums from Merck, Gilead, and ViiV. Dr. Sáez-Cirión will submit his slides in advance for adequate peer review and will support his presentation and clinical recommendations with the best available evidence from the medical literature. All relevant financial relationships have been mitigated.
- Dr. Rajesh T. Gandhi (Presenter) has no relevant financial relationships to disclose. Dr. Gandhi will submit his slides in advance for adequate peer review and will support his presentation and clinical recommendations with the best available evidence from the medical literature.

Financial Support:

This PRN CME activity is funded in part by unrestricted educational grants from:
Gilead Sciences; Janssen Therapeutics, a division of Janssen Products, LP; Merck & Co.; and ViiV Healthcare.